Source link : https://newshealth.biz/health-news/fda-approves-first-non-antipsychotic-drug-for-alzheimers-agitation/

The FDA expanded the indication for dextromethorphan hydrobromide and bupropion hydrochloride (Auvelity) extended-release tablets to treat agitation associated with Alzheimer’s disease dementia, the agency announced Thursday. This decision marks the first approved treatment for Alzheimer’s dementia that is not an antipsychotic, the FDA said. The drug initially was approved to treat major depressive disorder in […]

The post FDA Approves First Non-Antipsychotic Drug for Alzheimer’s Agitation first appeared on News Health.

—-

Author : News Health

Publish date : 2026-05-01 20:57:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678